Nektar Therapeutics (NKTR) Inventory Average (2011 - 2024)

Nektar Therapeutics' Inventory Average history runs 14 years deep, the most recent figure standing at $15.4 million for Q2 2024.

• On a quarterly basis, Inventory Average fell 24.98% year-over-year to $15.4 million in Q2 2024; TTM through Jun 2024 was $15.4 million, a 24.98% decrease from a year earlier, with the FY2023 full-year figure at $17.7 million, up 0.86% from the prior year.
• Inventory Average declined to $15.4 million in Q2 2024 per NKTR's latest filing, from $16.2 million in the prior quarter.
• Across five years, Inventory Average topped out at $20.5 million in Q2 2023 and bottomed at $12.7 million in Q3 2020.
• The 5-year median for Inventory Average is $15.7 million (2021), against an average of $16.1 million.
• Across the five-year window, Inventory Average advanced 26.51% in 2023 and dropped 24.98% in 2024, its largest moves.
• Year by year, Inventory Average stood at $14.1 million in 2020, then grew by 10.46% to $15.6 million in 2021, then advanced by 22.9% to $19.1 million in 2022, then declined by 18.37% to $15.6 million in 2023, then dropped by 1.69% to $15.4 million in 2024.
• Per Business Quant, the three latest NKTR Inventory Average figures stand at $15.4 million (Q2 2024), $16.2 million (Q1 2024), and $15.6 million (Q4 2023).